EBIT at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s EBIT?
- Phathom Pharmaceuticals, Inc. (PHAT) reported EBIT of -$15.48M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s EBIT changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s EBIT increased by 80.4% year-over-year, from -$78.86M to -$15.48M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s EBIT has grown at a 4.3% compound annual growth rate (CAGR), from -$135.08M to -$159.99M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.